HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Hooshang Bolooki Gerard A. Kaiser Richard J. Thurer Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bolooki, H. Articles by Kieval, J. Search for Related Content PubMed PubMed Citation Articles by Bolooki, H. Articles by Kieval, J.

Ann Thorac Surg 1983;36:246-252
© 1983 The Society of Thoracic Surgeons

---

Articles

Failure of Hancock Xenograft Valve: Importance of Valve Position (4- to 9-Year Follow-up)

From the Divisions of Thoracic and Cardiovascular Surgery and Cardiology, University of Miami School of Medicine, Jackson Memorial Hospital Center, Miami, FL

^* Address reprint requests to Dr. Bolooki, Thoracic and Cardiovascular Surgery R-114, PO Box 016960, Miami, FL 33101

To evaluate long-term durability of Hancock valves, we reviewed our results in 107 hospital survivors (120 valves) who were operated on during 1974 through mid-1979. Mitral valve replacement was done in 63 patients, aortic valve replacement in 20, and mitral valve replacement combined with other procedures in 24. The 7-year survival was 84 ± 4% (standard error of the mean) for 91 patients and 97 valves. During a follow-up of 590 patient-years, 15 (12 mitral and 3 aortic) of 120 valves at risk (87 mitral, 32 aortic, 1 tricuspid) were removed from 14 patients. Six valves (3 mitral and 3 aortic) were removed because of bacterial endocarditis. One mitral valve was removed because of thromboembolism. Eight mitral valves were removed because of valve structural failure, which occurred at a mean follow-up of 42 months. These valves showed extensive calcification, leaflet perforation, or cusp tear. Structural failure was unrelated to valve size, year of implantation, or valve shelf-life. Structural failure was not seen after aortic valve replacement.

Results show that structural failure of the Hancock xenograft valve in the mitral position is related primarily to valve position. After aortic valve replacement, valve failure is predominantly due to endocarditis. Although medium-term (mean, 6-year) durability of this xenograft valve compares satisfactorily with prosthetic valves, its high failure rate in the mitral position indicates the necessity for improvement in valve mounting, design, and preservation.

This article has been cited by other articles:

				H Oxenham, P Bloomfield, D J Wheatley, R J Lee, J Cunningham, R J Prescott, and H C Miller Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses Heart, July 1, 2003; 89(7): 715 - 721. [Abstract] [Full Text] [PDF]

				A. S. Geha Long-term Outcome of Cardiac Valve Substitutes Ann. Thorac. Surg., December 1, 1987; 44(6): 566 - 567. [PDF]

				A. H. Foster, G. J. Greenberg, D. J. Underhill, C. L. McIntosh, and R. E. Clark Intrinsic Failure of Hancock Mitral Bioprostheses: 10- to 15-Year Experience Ann. Thorac. Surg., December 1, 1987; 44(6): 568 - 577. [Abstract] [PDF]

				U. Bortolotti, A. Milano, G. Thiene, F. Guerra, A. Mazzucco, E. Talenti, and V. Gallucci Long-term Durability of the Hancock Porcine Bioprosthesis Following Combined Mitral and Aortic Valve Replacement: An 11-Year Experience Ann. Thorac. Surg., August 1, 1987; 44(2): 139 - 144. [Abstract] [PDF]

				A. Cobanoglu, W. R. E. Jamieson, D. C. Miller, C. McKinley, G. L. Grunkemeier, H. S. Floten, R. T. Miyagishima, G. F. O. Tyers, N. E. Shumway, and A. Starr A Tri-Institutional Comparison of Tissue and Mechanical Valves using a Patient-Oriented Definition of "Treatment Failure" Ann. Thorac. Surg., March 1, 1987; 43(3): 245 - 253. [Abstract] [PDF]

				H. Bolooki, G. A. Kaiser, S. M. Mallon, G. M. Palatianos, with the technical assistance of, S. Novak, and W. Feuer Comparison of Long-Term Results of Carpentier-Edwards and Hancock Bioprosthetic Valves Ann. Thorac. Surg., November 1, 1986; 42(5): 494 - 499. [Abstract] [PDF]

				F. Nistal, E. Artinano, and I. Gallo Primary Tissue Valve Degeneration in Glutaraldehyde-Preserved Porcine Bioprostheses: Hancock I Versus Carpentier-Edwards at 4- to 7-Years' Follow-up Ann. Thorac. Surg., November 1, 1986; 42(5): 568 - 572. [Abstract] [PDF]

				C. Zussa, G. Ottino, M. di Summa, G. A. Poletti, G. F. Zattera, S. Pansini, and M. Morea Porcine Cardiac Bioprostheses: Evaluation of Long-term Results in 990 Patients Ann. Thorac. Surg., March 1, 1985; 39(3): 243 - 250. [Abstract] [PDF]